Inflammation: Acute

Inflammation represents the response of vascularised tissue to damage resulting from infection or injury. An acute inflammatory response comprises four phases: detection of harmful stimuli, recruitment of effector molecules and cells, elimination of pathogens and cellular debris and restoration of tissue homeostasis. Several receptor families, including Toll-like receptors, Nod-like receptors and C-type lectins, recognise molecules associated with microbial pathogens and cellular damage. Signals mediated by these receptors stimulate the release of inflammatory molecules that alter vascular permeability at sites of tissue damage. Changes in vascular endothelium promote the exudation of plasma and the recruitment of leucocytes for the clearance of microorganisms and necrotic tissue. Inflammatory mediators also exert systemic effects that contribute to immune defence in a process called the acute-phase response. Successful clearance of injurious agents and tissue damage abates inflammatory signals and is followed by the formation of granulation tissue and the initiation of tissue remodelling.

Key Concepts:

  • Tissues are continuously surveyed for infection and cellular damage by cells and molecules that recognise pathogen- and damage-associated molecular patterns.
  • Recognition of infection or cellular damage activates inflammation locally and systemically to eliminate microbial pathogens and damaged tissue.
  • Inflammatory signals recruit neutrophils and macrophages into inflamed tissues where they release toxic factors and phagocytose pathogens and cellular debris.
  • The resolution of inflammation is followed by tissue repair and remodelling.

Keywords: coagulation; platelets; leucocytes; phagocytosis; wound healing; cytokines; neutrophils; macrophages; acute-phase response

Figure 1. Stages of the acute inflammatory response. (a) The inflammatory process begins with vascular coagulation (clotting) and the detection of pathogens or cellular injury by pattern recognition receptors (PRR). (b) Signalling through PRR induces inflammatory mediators which act on blood vessels to promote the recruitment of leucocytes and exudation of plasma into the damaged tissue. (c) After elimination of microorganisms and necrotic tissue, leucocyte recruitment ceases and apoptotic neutrophils are phagocytosed by macrophages. (d) Tissue repair and remodelling involves the development of new blood vessels (angiogenesis), resurfacing of the wound (re-epithelialisation) and collagen deposition.
Figure 2. Clot formation. Tissue injury results in fibrin formation to form the blood clot, which stops the bleeding and provides the scaffolding on which platelets aggregate and release mediators. The mediators influence vascular permeability and attract leucocytes from the blood. L, lymphocyte; M, macrophage and N, neutrophil.
Figure 3. Leucocyte adhesion and recruitment. At a site of inflammation, activated vascular endothelial cells express adhesion receptors which bind leucocytes that bear the matching adhesion molecules. This initially slows the leucocytes down, allowing them to sense the environment and then to attach more firmly and migrate between the endothelial cells to the inflamed tissue. N, neutrophil; M, macrophage; L, lymphocyte and VCAM, vascular cell adhesion molecule. Illustration by Jeffrey Aarons.
Figure 4. Phagocytosis. Once in the inflamed tissue, neutrophils and macrophages take up tissue debris and microorganisms. Bacteria are rapidly recognised if they are opsonised (coated by antibodies or complement) by the Fc and C3 receptors. Pseudopodia wrap around the attached particle and engulf it into a phagocytic vacuole. Lysosomes, which contain microbicidal enzymes, fuse with the phagocytic vacuole to form a phagolysosome, where the particles are digested. Illustration by Jeffrey Aarons.
Figure 5. Healing and scar formation. As the inflammation is resolved, leucocytes, especially macrophages (M), release growth factors which stimulate fibroblasts to divide and to make new extracellular matrix (scar) to heal injured tissue. FGF, fibroblast growth factor; PDGF, platelet-derived growth factor and TGF, transforming growth factor . Illustration by Jeffrey Aarons.
close
 Further Reading
    Baggiolini M (1998) Chemokines and leucocyte traffic. Nature 392: 565–568.
    Brown E (1997) Neutrophil adhesion and the therapy of inflammation. Seminars in Hematology 34(4): 319–326.
    Dallegri F and Ottonello L (1997) Tissue injury in neutrophilic inflammation. Inflammation Research 46: 382–391.
    Matzinger P (2007) Friendly and dangerous signals: is the tissue in control? Nature Immunology 8: 11–13.
    Medzhitov R and Hornung T (2009) Transcriptional control of the inflammatory response. Nature Reviews. Immunology 9: 692–703.
    book Rosenberg HF and Gallin JI (1999) "Inflammation". In: Paul W (ed.) Fundamental Immunology, 4th edn, pp. 1051–1066. Philadelphia, PA: Lippincott-Raven Press.
    Savill J (1997) Apoptosis in resolution of inflammation. Journal of Leucocyte Biology 61(4): 375–380.
    book Wahl LM and Wahl SM (1992) "Inflammation". In: Cohen IK, Dieglemann RF and Lindblad WJ (eds) Wound Healing: Biochemical and Clinical Aspects, pp. 40–60. Philadelphia, PA: WB Saunders.
    Wahl S, Feldman GM and McCarthy JB (1996) Regulation of leucocyte adhesion and signaling in inflammation and disease. Journal of Leucocyte Biology 59: 789–796.
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Cain, Derek W, and Kelsoe, Garnett(Apr 2010) Inflammation: Acute. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0000943.pub2]